Researchers have found that medicines called JAK inhibitors halted tumor growth in patients with colon cancer who had a genetic mutation that is present in more than 80% of patients. Read more and read the study abstract.
© 2020 HealthCom Media
All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder